JP2010504934A5 - - Google Patents

Download PDF

Info

Publication number
JP2010504934A5
JP2010504934A5 JP2009529613A JP2009529613A JP2010504934A5 JP 2010504934 A5 JP2010504934 A5 JP 2010504934A5 JP 2009529613 A JP2009529613 A JP 2009529613A JP 2009529613 A JP2009529613 A JP 2009529613A JP 2010504934 A5 JP2010504934 A5 JP 2010504934A5
Authority
JP
Japan
Prior art keywords
cyclic
acid
pharmaceutical composition
compound
diagnostic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009529613A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010504934A (ja
JP5335677B2 (ja
Filing date
Publication date
Priority claimed from EP06020286A external-priority patent/EP1905454A1/en
Application filed filed Critical
Publication of JP2010504934A publication Critical patent/JP2010504934A/ja
Publication of JP2010504934A5 publication Critical patent/JP2010504934A5/ja
Application granted granted Critical
Publication of JP5335677B2 publication Critical patent/JP5335677B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009529613A 2006-09-27 2007-09-27 環状化合物を含む製剤 Expired - Fee Related JP5335677B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06020286.8 2006-09-27
EP06020286A EP1905454A1 (en) 2006-09-27 2006-09-27 Formulations comprising cyclic compounds
PCT/EP2007/008442 WO2008037484A2 (en) 2006-09-27 2007-09-27 Formulations comprising cyclic compounds

Publications (3)

Publication Number Publication Date
JP2010504934A JP2010504934A (ja) 2010-02-18
JP2010504934A5 true JP2010504934A5 (enExample) 2010-12-09
JP5335677B2 JP5335677B2 (ja) 2013-11-06

Family

ID=37728182

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009529613A Expired - Fee Related JP5335677B2 (ja) 2006-09-27 2007-09-27 環状化合物を含む製剤

Country Status (10)

Country Link
US (1) US8513188B2 (enExample)
EP (2) EP1905454A1 (enExample)
JP (1) JP5335677B2 (enExample)
CN (2) CN101557829A (enExample)
AU (1) AU2007302270B2 (enExample)
BR (1) BRPI0714761B8 (enExample)
CA (1) CA2664568C (enExample)
ES (1) ES2691736T3 (enExample)
IL (1) IL197760A (enExample)
WO (1) WO2008037484A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2504019A2 (en) 2009-11-25 2012-10-03 ArisGen SA Mucosal delivery composition comprising a peptide complexed with a crown compound and/or a counter ion
EP2332929A1 (en) * 2009-11-25 2011-06-15 ArisGen SA Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions
EP2526971A1 (en) * 2011-05-25 2012-11-28 ArisGen SA Mucosal delivery of drugs
CN102863358B (zh) * 2012-09-20 2014-02-12 华中农业大学 具有除草活性的化合物及其制备方法
EP3000811B1 (en) * 2014-09-24 2017-11-08 Friedrich-Alexander-Universität Erlangen-Nürnberg Crown Ether Complexes and Methods for Poducing the Same
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
CN108658264B (zh) * 2018-04-17 2021-05-25 唐山师范学院 多支化聚环氧琥珀酸衍生物阻垢缓蚀剂的制备及其应用方法
CN113527672B (zh) * 2020-03-30 2022-09-20 复旦大学 一种胍基衍生物及其基因递释系统
CN116178887B (zh) * 2023-02-16 2024-10-29 东华大学 一种可降解快递袋材料及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
US4474753A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Topical drug delivery system utilizing thermosetting gels
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
WO1987003473A1 (en) * 1985-12-04 1987-06-18 Dean Hsieh Transdermal delivery of drugs
ES2395096T3 (es) * 1999-06-29 2013-02-08 Mannkind Corporation Purificación y estabilización de agentes farmacéuticos a base de péptidos y proteínas
WO2001021612A1 (en) * 1999-09-20 2001-03-29 Amato Pharmaceutical Products, Ltd. Process for the preparation of cyclic lactic acid oligomers
WO2003049772A2 (en) * 2001-12-11 2003-06-19 The Board Of Trustees Of The Leland Stanford Junior University Guanidinium transport reagents and conjugates
JP2006232909A (ja) * 2005-02-23 2006-09-07 Tokai Univ 環状オリゴ乳酸

Similar Documents

Publication Publication Date Title
JP2010504934A5 (enExample)
JP5335677B2 (ja) 環状化合物を含む製剤
CN102112485B (zh) 乙酸格拉默(glatiramer acetate)的合成
CN110606947A (zh) 强碱引发n-羧基环内酸酐的快速开环聚合方法
Sun et al. Peptoid applications in biomedicine and nanotechnology
WO2011134284A1 (zh) 胰高血糖素样肽-1类似物及其应用
US20180256727A1 (en) Pharmaceutically Active Agent Complexes, Polymer Complexes, And Compositions And Methods Involving the Same
Fukuzumi et al. Chemoselective cyclization of unprotected linear peptides by α-ketoacid–hydroxylamine amide-ligation
RU2003123491A (ru) Лекарственная комбинация из бигуанида и переносчика, например из метформина и аргинина
CN115403663B (zh) 一种PTP1B多肽抑制剂BimBH3-12-I8A及其应用
Métro et al. Amino Acids and Peptides in Ball Milling
JPH0782225A (ja) アミノ酸誘導体及びその用途
JP2008291207A (ja) 塩基性アミノ酸を有するらせん状ポリマー
WO2019243628A1 (fr) Composition injectable a ph 7 comprenant un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes et au moins une insuline basale presentant au moins un effet prandial et un effet basal
WO2020025826A1 (fr) Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline, au moins une espece ionique et un compose amphiphile porteur de radicaux hydrophobes
CN1296360C (zh) (1r,2r)-或(1s,2s)-1-(4'-取代-1',8'-萘酰亚胺基)-2-氨基环己烷及其制法和用途
CN116808231A (zh) 一种细胞穿膜肽偶联舒必利前药体系以及制备方法和应用
Hartwig et al. From peptides to their alternating ester-urea analogues: synthesis and influence of hydrogen bonding motif and stereochemistry on aggregation
CN102558308B (zh) 一种用于形成药物复合物的载体多肽、制备方法及其用途
WO2023048236A1 (ja) ペプチド
CN103275253A (zh) 基于弹性蛋白肽的温度敏感型聚合物分子刷及其制备方法
JP2009096929A (ja) 擬似ペプチドライブラリー
JP2016166151A (ja) ペプチド化合物及びペプチド化合物の製造方法
JPWO2022247773A5 (enExample)
JP7659541B2 (ja) アミド結合含有化合物の製造方法